GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Diamond Biotechnology Co Ltd (ROCO:6815) » Definitions » Additional Paid-In Capital

Diamond Biotechnology Co (ROCO:6815) Additional Paid-In Capital : NT$195.7 Mil(As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Diamond Biotechnology Co Additional Paid-In Capital?


Diamond Biotechnology Co's quarterly additional paid-in capital increased from Dec. 2023 (NT$0.0 Mil) to Jun. 2024 (NT$195.0 Mil) and increased from Jun. 2024 (NT$195.0 Mil) to Dec. 2024 (NT$195.7 Mil).

Diamond Biotechnology Co's annual additional paid-in capital stayed the same from Dec. 2022 (NT$0.0 Mil) to Dec. 2023 (NT$0.0 Mil) but then increased from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$195.7 Mil).


Diamond Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for Diamond Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biotechnology Co Additional Paid-In Capital Chart

Diamond Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial - - - - 195.71

Diamond Biotechnology Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 195.00 195.71

Diamond Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Diamond Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Diamond Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamond Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 45, Section 2, Fuxing South Road, Da'an District, 11th Floor, Taipei, TWN
Diamond Biotechnology Co Ltd is engaged in the research and development of medical equipment, and medical consumables. It also manufactures and sells medical beauty-level skincare products.

Diamond Biotechnology Co Headlines

No Headlines